Erythrocytes anion transport and oxidative change in β-thalassaemias

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 655-662

  Maria, Crupi ^a   Leonardo, Romano ^b   Pietro, Romano ^a   Mario, Venza ^a   Isabella, Venza ^a   Diana, Teti ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Department of General Physiology and Pharmacology   (Italy)

Author keywords

Band 3 protein; Inhibitor; Iron; Magnesium; Oxidative stress; Sulfate uptake

Indexed keywords

ERYTHROCYTE BAND 3 PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; MAGNESIUM ION; MEMBRANE PROTEIN; POTASSIUM ION; SULFATE; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ANTIOXIDANT; IRON; MAGNESIUM; POTASSIUM;

ACID BASE BALANCE; ANION EXCHANGE; ANION TRANSPORT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; OXIDATIVE STRESS; POTASSIUM TRANSPORT; PROTEIN FUNCTION; REGULATORY MECHANISM; BLOOD; DRUG ANTAGONISM; ENZYMOLOGY; ERYTHROCYTE; ION TRANSPORT; METABOLISM; PATHOLOGY;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIOXIDANTS; BETA-THALASSEMIA; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; HUMANS; ION TRANSPORT; IRON; MAGNESIUM; OXIDATIVE STRESS; POTASSIUM; SULFATES;

EID: 77955072691     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090472     Document Type: Article

References (53)

1. Adragna NC, Lauf PK. Oxidative activation of K-Cl co-transport by Diamide in erythrocytes from humans with red cell disorders, and from several other mammalian species. J Membr Biol 1997;155:207-17.
2. Advani R, Sorenson S, Shinar E, Lande W, Rachmilewitz EA, Schrier SL. Characterization and comparison of the red blood cell membrane damage in severe human α and β thalassemia. Blood 1992;79:1058-63.
3. Aljurf A, Ma L, Angelucci E, Lucarelli G, Snyder LM, Kiefer CR, Yuan J, Schrier SL. Abnormal assembly of membrane proteins in erythroid progenitors of patients with β-thalassemia major. Blood 1996;87:2049-56.
4. Amer J, Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 2004;92:1052-9.
5. Amer J, Ghoti H, Rachmilewitz EA, Koren A, Levin C, Fibach E. Red blood cells, platelets and polymorphonuclear neutrophilis of patients with sickle cell disease exibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2006;132:108-13.
6. Amer J, Goldfarb A, Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Citometry A 2004;60:73-80.
7. Beutler E, Blume KG, Keplan C, Lohr W, Ramat B, Valentine WN. International committee for standardization in haematology. Reccomended screening test for glucose-6-phosphatase dehydrogenase (G-6-PD). Br J Haematol 1979;43:469-77.
8. Bize I, Guvenc B, Buchbinder G, Brugnara C. Stimulation of human erythrocyte K-Cl co-transport and protein phosphatase type 2A by n-ethylmaleimide: role of intracellular Mg++. J Membr Biol 2000;177:159-68.
9. Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int J Haematol 2002;76:219-28.
10. Cabantchik ZI, Rothstein A. Membrane proteins related to anion permeability of human red blood cells. I localization of disulfonic stilbene binding sites in proteins involved in permeation. J Membr Biol 1974;15:207-26.
11. Cappellini MD, Gavazzi D, Duca L, Graziadei G, Mannu F, Turrini F, Arese P, Fiorelli G. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in β thalassemia intermedia. Br J Haematol 1999;104:504-12.
12. Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebetathalassemia. Clin Chim Acta 2001;305:123-9.
13. Cheng ML, Ho HY, Lee CH, Shih LY, Chiu DT. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of alpha-thalassemia. Br J Haematol 2005;128:119-27.
14. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002;32:568-76.
15. Das N, Chowdhury, T, Chattopadhyay A, Datta AG. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol 2004;56:85-96.
16. Datta P, Basu S, Chakravarty SB, Chakravarty A, Banerjee D, Chandra S, Chakravarty A. Enhanced oxidative cross-linking of haemoglobin E with spectrin and loss of erythrocyte membrane asymmetry in haemoglobin Ebeta-thalassemia. Blood Cells Mol Dis 2006;37:77-81.
17. De Franceschi L, Cappellini MD, Graziadei G, Manzato F, Olivieri O, Corrocher R, Fiorelli G, Beuzard Y, Brugnara C. The effect of dietary magnesium supplementation on the cellular G6PDH-deficientities of erythrocytes in patients with beta thalassemia intermedia. Haematologica 1998;83:118-25.
18. De Franceschi L, Villa-Moruzzi E, Fumagalli L, Brugnara C, Turrini F, Motta R, Veghini E, Corato C, Alper SL, Berton G. K-Cl cotransport modulation by Mg in erythrocytes from mice bred for low and high Mg levels. Am J Physiol Cell Physiol 2001;281:C1385-95.
19. De Mattia D, Pettini PL, Sabato V, Rubini G, Laforgia A, Schettini F. Oromaxillofacial changes in thalassemia major. Minerva Pediatr 1996;48:11-20.
20. Dhawan V, Kumar KR, Marwaha RK, Ganguly NK. Antioxidant status in children with homozygous thalassemia. Indian Pediatr 2005;42:1141-5.
21. Fujise H, Higa K, Kanemaru T, Fukuda M, Adragna NC, Lauf PK. GSH depletion, K-Cl co-trasport, and regulatory volume decrease in high-K/high-GSH dog red blood cells. Am J Physiol Cell Physiol 2001;281:C2003-9.
22. Gartaganis SP, Georgakopoulos CD, Exarchou A, Mela EK, Psachoulia C, Eliopoulou MI, Kourakli A, Gotsis SS, Tripathi RC. Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia. Cornea 2003;22:591-7.
23. Giger U, Sticher B, Naef R, Burger R, Lutz HU. Naturally occurring human anti-band 3 autoantibodies accelerate clearance of erythrocytes in guinea pigs. Blood 1995;85:1920-8.
24. Gotte P, Consolo U, Faccioni F, Bertoldi C. Associated orthodontic, surgical and hematological management of Cooley s anemia. Report of a case. Minerva Stomatol 2001;50:47-54.
25. -, ionic strength, and volume changes. Am J Physiol Cell Physiol 1999;276:C210-20.
26. 2 and orthovanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 1990;265:2896-902.
27. Jensen FB, Jakobsen MH, Weber RE. Interaction between haemoglobin and synthetic peptides of the N-terminal cytoplasmic fragment of trout band 3 (AE1) protein. J Exp Biol 1998;201:2685-90.
28. + efflux (Gardos effect) in orthovanadate-treated and ATP-depleted human red blood cells. Gen Physiol Biophys 2002;21:429-42.
29. Kassab-Chekri A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, Amri F, Selmi H, Bejaoui M, Miled A. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003;338:79-86.
30. Khan MT, Saleemijddin M. Unlike its human counterpart, band 3 anion exchange protein from goat erythrocyte membrane shows a lack of reactivity against various -SH oxidants and protease treatments. Comp Biochem Physiol Biochem Molec Biol 1995;110:399-43.
31. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E, Häussinger D. Functional significance of cell volume regulatory mechanism. Physiol Rev 1998;78:247-306.
32. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-56.
33. Lauf PK, Adragna NC. Proton (H+) modulation of K-Cl co-transport through both internal and external sites in DIDS-pH-clamped low magnesium LK sheep erythrocytes. Biophys J 1997;72:A408.
34. 2DIDS). J Membr Biol 1976;29:147-77.
35. Lytle C, McManus T. Coordinate modulation of Na-K-2KCl co-transport and K-Cl co-transport by cell volume and chloride. Am J Physiol Cell Physiol 2002;283:C1422-31.
36. Minetti G, Seppi C, Ciana A, Balduini C, Low PS, Brovelli A. Characterization of the hypertonically induced tyrosine phosphorylation of erythrocyte band 3. Biochem J 1998;335(Pt 2):305-11.
37. Monteiro HP, Ivaschenko Y, Fischer R, Stern A. Inhibition of protein tyrosine phosphatase activity by Diamide is reversed by epidermal growth factor in fibroblasts. FEBS Lett 1991;295:146-8.
38. Olivieri O, De Franceschi L, Capellini MD, Girelli D, Corrocher R, Brugnara C. Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood 1994;84:315-20.
39. Olivieri O, Vitoux D, Galacteros F. Hemoglobin variants and activity of K/Cl cotrasport system in human erythrocytes. Blood 1992;79:793-7.
40. Pesarin F. Multivariate Permutation Test. New York: Wiley; 2001. pp. 37-69.
41. Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Breda L, Rivella S, Cabantchik ZI. Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci 2005;1054:118-23.
42. Salhany JM, Sloan RL, Cordes KA. In situ cross-linking of human erythrocyte band 3 by bis(sulfosuccinimidyl)suberate. Evidence for ligand modulation of two alternate quaternary forms: covalent band 3 dimers and noncovalent tetramers formed by the association of two covalent dimers. Boca J Biol Chem 1990;15:17688-93.
43. Schrier SL, Mohandas N. Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties. Blood 1992;79:1586-92.
44. Schrier SL, Rachmilewitz EA, Mohandas N. Cellular and membrane properties of α and β thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood 1989;74:2194-202.
45. Shinar E, Rachmilewitz EA, Lux SE. Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest 1989;83:404-10.
46. Shinar E, Shalev EA, Rachmilewitz EA, Schrier SL. Erythrocyte membrane skeleton abnormalities in severe β-thalassemia. Blood 1987;70:158-64.
47. Sultanov MIu, Gadzhieva NM. Ocular function in beta-thalassemia patients. Vestn Oftalmol 1992;108:42-5.
48. Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P. Ocular findings among thalassemia patients. Am J Ophthalmol 2006;142:704-5.
49. Tesoriere L, D'Arpa D, Butera D, Allegra M, Renda D, Maggio A, Buongiorno A, Livrea MA. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic Res 2001;34:529-40.
50. Teti D, Crupi M, Busa' M, Valenti A, Loddo S, Mondello M, Romano L. Chemical and pathological oxidative influences on band 3 protein anion-exchanger. Cell Physiol Biochem 2005;16:77-86.
51. Turrini F, Mannu F, Cappadoro M, Ulliers D, Giribaldi G, Arese P. Binding of naturally occurring antibodies to oxidatively and nonoxidatively modified erythrocyte band 3. Biochim Biophys Acta 1994;1190:297-303.
52. Yannoukakos D, Meyer HE, Vasseur C, Driancourt C, Wajcman H, Bursaux E. Three regions of erythrocyte band 3 protein are phosphorylated on tyrosines: characterization of the phosphorilation sites by solid phase sequencing combined capillary electrophoresis. Biochim Biophys Acta 1991;1066:70-6.
53. Zipser Y, Piade A, Kosower NS. Erythrocyte thiol state regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Letters 1997;406:126-30.